TrialJAMA psychiatry2018

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.

Daniel C Javitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.